Cosmo Pharmaceuticals
C43.F
#5365
Rank
HK$8.60 B
Marketcap
HK$534.71
Share price
-1.50%
Change (1 day)
54.97%
Change (1 year)

Earnings for Cosmo Pharmaceuticals (C43.F)

Earnings in 2022: HK$0.20 Billion

According to Cosmo Pharmaceuticals's latest financial reports the company's current earnings are HK$0.10 Billion. In 2022 the company made an earning of HK$0.20 Billion a decrease over its 2021 earnings that were of HK$0.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cosmo Pharmaceuticals from 2004 to 2022

Annual earnings

Year Earnings Change
2022HK$0.20 B-3.43%
2021HK$0.21 B-418.87%
2020-HK$66.36 Million-64.28%
2019-HK$0.19 Billion19.49%
2018-HK$0.16 Billion-48.67%
2017-HK$0.31 Billion-234.57%
2016HK$0.22 B-89.6%
2015HK$2.16 B110.02%
2014HK$1.03 B33.75%
2013HK$0.77 B177.69%
2012HK$0.27 B201.84%
2011HK$91.9 M99.1%
2010HK$46.16 M-22.14%
2009HK$59.28 M-53.08%
2008HK$0.12 B7167.3%
2007HK$1.73 M-66.41%
2006HK$5.17 M-57.18%
2005HK$12.08 M-193.84%
2004-HK$12.89 Million